Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphasic Insulin Aspart 30 in Insulin Naive Type 2 Diabetes
NCT00600366Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2004
- Primary completion
- Jan 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of biphasic insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2004; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00600366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600366.